Noble Wealth Management PBC’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$816 Buy
+10
New +$722 ﹤0.01% 740

Other funds holding PTCT

Noble Wealth Management PBC's PTCT Position: Q2 2026 in Review

Noble Wealth Management PBC opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 10 shares worth $816. The stake represents ﹤0.01% of the portfolio and ranks #740 among its holdings.

78 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Noble Wealth Management PBC held 10 shares of PTC Therapeutics worth $816 as of Q2 2026.
  • PTC Therapeutics was a new Noble Wealth Management PBC position in Q2 2026.
  • PTC Therapeutics made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q2 2026, its #740 holding.
  • 78 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Noble Wealth Management PBC's 13F filing for Q2 2026, filed 1 Jul 2026.